Table of Contents
Journal of Allergy
Volume 2012, Article ID 580873, 9 pages
http://dx.doi.org/10.1155/2012/580873
Research Article

Comparison of CD63 Upregulation Induced by NSAIDs on Basophils and Monocytes in Patients with NSAID Hypersensitivity

1Service d'Hématologie et d'Immunologie Biologique, Hôpital Tenon (AP-HP), Université Pierre et Marie Curie, 4 Rue de la Chine, 75020 Paris, France
2Service de Dermatologie et Allergologie, Hôpital Tenon (AP-HP), Université Pierre et Marie Curie, 4 Rue de la Chine, 75020 Paris, France

Received 28 June 2011; Accepted 11 September 2011

Academic Editor: Hae-Sim Park

Copyright © 2012 N. Abuaf et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Kasper, K. Sladek, M. Duplaga et al., “Prevalence of asthma with aspirin hypersensitivity in the adult population of Poland,” Allergy, vol. 58, no. 10, pp. 1064–1066, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Juhlin, “Recurrent urticaria: clinical investigation of 330 patients,” British Journal of Dermatology, vol. 104, no. 4, pp. 369–381, 1981. View at Google Scholar · View at Scopus
  3. M. Setkowicz, L. Mastalerz, M. Podolec-Rubis, M. Sanak, and A. Szczeklik, “Clinical course and urinary eicosanoids in patients with aspirin-induced urticaria followed up for 4 years,” Journal of Allergy and Clinical Immunology, vol. 123, no. 1, pp. 174–178, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. D. D. Stevenson and R. A. Simon, “Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma,” Journal of Allergy and Clinical Immunology, vol. 108, no. 1, pp. 47–51, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Zembowicz, L. Mastalerz, M. Setkowicz, W. Radziszewski, and A. Szczeklik, “Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs,” Archives of Dermatology, vol. 139, no. 12, pp. 1577–1582, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Mastalerz, M. Setkowicz, M. Sanak, and A. Szczeklik, “Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma,” Journal of Allergy and Clinical Immunology, vol. 113, no. 4, pp. 771–775, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. M. L. Sanz, P. Gamboa, and A. L. de Weck, “A new combined test with flowcytometric basophil activation and determination of sulfidoleukotrienes is useful for in vitro diagnosis of hypersensitivity to aspirin and other nonsteroidal anti-inflammatory drugs,” International Archives of Allergy and Immunology, vol. 136, no. 1, pp. 58–72, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. M. L. Kowalski, A. Ptasinska, M. Jedrzejczak et al., “Aspirin-triggered 15-HETE generation in peripheral blood leukocytes is a specific and sensitive aspirin-sensitive patients identification test (ASPITest),” Allergy, vol. 60, no. 9, pp. 1139–1145, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Kupczyk, A. Antczak, I. Kuprys-Lipinska, and P. Kuna, “Lipoxin A4 generation is decreased in aspirin-sensitive patients in lysine-aspirin nasal challenge in vivo model,” Allergy, vol. 64, no. 12, pp. 1746–1752, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. M. J. Torres-Galván, N. Ortega, F. Sánchez-García, C. Blanco, T. Carrillo, and J. Quiralte, “LTC4-synthase A-444C polymorphism: lack of association with NSAID-induced isolated periorbital angioedema in a Spanish population,” Annals of Allergy, Asthma and Immunology, vol. 87, no. 6, pp. 506–510, 2001. View at Google Scholar · View at Scopus
  11. L. Mastalerz, M. Setkowicz, M. Sanak, H. Rybarczyk, and A. Szczeklik, “Familial aggregation of aspirin-induced urticaria and leukotriene C synthase allelic variant,” British Journal of Dermatology, vol. 154, no. 2, pp. 256–260, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. H. A. Kim, Y. M. Ye, S. H. Kim, G. Y. Hur, and H. S. Park, “Association of β2-adrenergic receptor polymorphism with the phenotype of aspirin-intolerant acute urticaria,” Yonsei Medical Journal, vol. 48, no. 6, pp. 1079–1081, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. J. S. Bae, S. H. Kim, Y. M. Ye et al., “Significant association of FcεRIα promoter polymorphisms with aspirin-intolerant chronic urticaria,” Journal of Allergy and Clinical Immunology, vol. 119, no. 2, pp. 449–456, 2007. View at Publisher · View at Google Scholar
  14. S. H. Kim, J. H. Choi, K. W. Lee et al., “The human leucocyte antigen-DRB1*1302-DQB1*0609-DPB1*0201 haplotype may be a strong genetic marker for aspirin-induced urticaria,” Clinical and Experimental Allergy, vol. 35, no. 3, pp. 339–344, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Cryer and M. Feldman, “Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs,” American Journal of Medicine, vol. 104, no. 5, pp. 413–421, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Kato, S. Nishida, H. Kitasato, N. Sakata, and S. Kawai, “Cyclooxygenase-1 and cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs: investigation using human peripheral monocytes,” Journal of Pharmacy and Pharmacology, vol. 53, no. 12, pp. 1679–1685, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Hinz, O. Cheremina, and K. Brune, “Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man,” FASEB Journal, vol. 22, no. 2, pp. 383–390, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Ring and H. Behrendt, “Anaphylaxis and anaphylactoid reactions: classification and pathophysiology,” Clinical Reviews in Allergy and Immunology, vol. 17, no. 4, pp. 387–399, 1999. View at Google Scholar · View at Scopus
  19. D. Messaad, H. Sahla, S. Benahmed, P. Godard, J. Bousquet, and P. Demoly, “Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction,” Annals of Internal Medicine, vol. 140, no. 12, pp. 1001–1006, 2004. View at Google Scholar · View at Scopus
  20. B. Schubert, M. T. G. Perdekamp, P. Pfeuffer, P. Raith, E. B. Bröcker, and A. Trautmann, “Nonsteroidal anti-inflammatory drug hypersensitivity: fable or reality?” European Journal of Dermatology, vol. 15, no. 3, pp. 164–167, 2005. View at Google Scholar · View at Scopus
  21. M. L. Kowalski, J. S. Makowska, M. Blanca et al., “Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs)—classification, diagnosis and management: review of the EAACI/ENDA and GA2LEN/HANNA,” Allergy, vol. 66, no. 7, pp. 818–829, 2011. View at Publisher · View at Google Scholar
  22. P. Gamboa, M. L. Sanz, M. R. Caballero et al., “The flow-cytometric determination of basophil activation induced by aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is useful for in vitro diagnosis of the NSAID hypersensitivity syndrome,” Clinical and Experimental Allergy, vol. 34, no. 9, pp. 1448–1457, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Rodríguez-Trabado, C. Cámara-Hijón, A. Ramos-Cantariño et al., “Basophil activation test for the in vitro diagnosis of nonsteroidal anti-inflammatory drug hypersensitivity,” Allergy and Asthma Proceedings, vol. 29, no. 3, pp. 241–249, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. S. M. Erdmann, S. Ventocilla, S. Moll-Slodowy, I. Sauer, and H. F. Merk, “Basophil activation tests in the diagnosis of drug reactions,” Hautarzt, vol. 56, no. 1, pp. 38–43, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Malbrán, E. Yeyati, G. L. Rey, and N. Galassi, “Diclofenac induces basophil degranulation without increasing CD63 expression in sensitive patients,” Clinical and Experimental Immunology, vol. 147, no. 1, pp. 99–105, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. A. L. de Weck, M. L. Sanz, P. M. Gamboa et al., “Nonsteroidal anti-inflammatory drug hypersensitivity syndrome. A multicenter study I. Clinical findings and in vitro diagnosis,” Journal of Investigational Allergology and Clinical Immunology, vol. 19, no. 5, pp. 355–369, 2009. View at Google Scholar
  27. S. J. Choi, Y. M. Ye, G. Y. Hur, S. Y. Shin, J. H. Han, and H. S. Park, “Neutrophil activation in patients with ASA-induced urticaria,” Journal of Clinical Immunology, vol. 28, no. 3, pp. 244–249, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Grattan, S. Powell, and F. Humphreys, “Management and diagnostic guidelines for urticaria and angio-oedema,” British Journal of Dermatology, vol. 144, no. 4, pp. 708–714, 2001. View at Publisher · View at Google Scholar
  29. E. Nettis, A. Pannofino, C. D'Aprile, A. Ferrannini, and A. Tursi, “Clinical and aetiological aspects in urticaria and angio-oedema,” British Journal of Dermatology, vol. 148, no. 3, pp. 501–506, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Abuaf, B. Rajoely, E. Ghazouani et al., “Validation of a flow cytometric assay detecting in vitro basophil activation for the diagnosis of muscle relaxant allergy,” Journal of Allergy and Clinical Immunology, vol. 104, no. 2 I, pp. 411–418, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. N. Abuaf, H. Rostane, B. Rajoely et al., “Comparison of two basophil activation markers CD63 and CD203c in the diagnosis of amoxicillin allergy,” Clinical and Experimental Allergy, vol. 38, no. 6, pp. 921–928, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Han, Y. Kim, J. Lee et al., “Human basophils express CD22 without expression of CD19,” Cytometry, vol. 37, no. 3, pp. 178–183, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. F. F. Fagnoni, B. Oliviero, C. Zibera et al., “Circulating CD33+ large mononuclear cells contain three distinct populations with phenotype of putative antigen-presenting cells including myeloid dendritic cells and CD14+ monocytes with their CD16+ subset,” Cytometry, vol. 45, no. 2, pp. 124–132, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. H. J. Bühring, A. Streble, and P. Valent, “The basophil-specific ectoenzyme E-NPP3 (CD203c) as a marker for cell activation and allergy diagnosis,” International Archives of Allergy and Immunology, vol. 133, no. 4, pp. 317–329, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Boumiza, G. Monneret, M. F. Forissier et al., “Marked improvement of the basophil activation test by detecting CD203c instead of CD63,” Clinical and Experimental Allergy, vol. 33, no. 2, pp. 259–265, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. G. E. Çelik, J. T. Schroeder, R. G. Hamilton, S. S. Saini, and N. F. Adkinson, “Effect of in vitro aspirin stimulation on basophils in patients with aspirin-exacerbated respiratory disease,” Clinical and Experimental Allergy, vol. 39, no. 10, pp. 1522–1531, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Wismol, P. Putivoranat, S. Buranapraditkun, P. Pinnobphun, K. Ruxrungtham, and J. Klaewsongkram, “The values of nasal provocation test and basophil activation test in the different patterns of ASA/NSAID hypersensitivity,” Allergologia et Immunopathologia. In press. View at Publisher · View at Google Scholar
  38. S. Bavbek, A. Kincioǧullari, A. B. Dursun et al., “Upregulation of CD63 or CD203c alone or in combination is not sensitive in the diagnosis of nonsteroidal anti-inflammatory drug intolerance,” International Archives of Allergy and Immunology, vol. 150, no. 3, pp. 261–270, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. R. Asero, “Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria,” Journal of Allergy and Clinical Immunology, vol. 111, no. 5, pp. 1095–1098, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. A. L. de Weck, M. L. Sanz, P. M. Gamboa et al., “Nonsteroidal anti-inflammatory drug hypersensitivity syndrome: a multicenter study II. Basophil activation by nonsteroidal anti-inflammatory drugs and its impact on pathogenesis,” Journal of Investigational Allergology and Clinical Immunology, vol. 20, no. 1, pp. 39–57, 2010. View at Google Scholar · View at Scopus
  41. A. L. de Weck, M. L. Sanz, P. M. Gamboa et al., “Diagnostic tests based on human basophils: more potentials and perspectives than pitfalls,” International Archives of Allergy and Immunology, vol. 146, no. 3, pp. 177–189, 2008. View at Publisher · View at Google Scholar · View at Scopus